Hui Zeng

2.1k total citations
81 papers, 1.4k citations indexed

About

Hui Zeng is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Hui Zeng has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Hematology and 19 papers in Cancer Research. Recurrent topics in Hui Zeng's work include Acute Myeloid Leukemia Research (15 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (9 papers). Hui Zeng is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (9 papers). Hui Zeng collaborates with scholars based in China, United States and United Kingdom. Hui Zeng's co-authors include Juan Du, Kristen Martins‐Taylor, Xiaofang Wang, Tianming Zhao, Kevin G. Otto, Fangping Chen, Liqing Jin, C. Anthony Blau, Min Guo and Ge Lin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

In The Last Decade

Hui Zeng

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Zeng China 21 929 324 228 154 140 81 1.4k
Zhihong Wang China 22 1.2k 1.3× 334 1.0× 237 1.0× 103 0.7× 98 0.7× 81 1.6k
Petra Obexer Austria 24 1.2k 1.3× 325 1.0× 396 1.7× 90 0.6× 248 1.8× 43 1.8k
Fengjuan Fan China 24 1.3k 1.3× 349 1.1× 461 2.0× 234 1.5× 267 1.9× 67 1.9k
Xueyan Wang China 18 1.4k 1.5× 380 1.2× 423 1.9× 89 0.6× 114 0.8× 61 2.0k
Lijun Di China 25 1.0k 1.1× 389 1.2× 602 2.6× 104 0.7× 236 1.7× 102 1.9k
Joan Chang United Kingdom 20 683 0.7× 222 0.7× 329 1.4× 60 0.4× 179 1.3× 33 1.5k
Alex R. D. Delbridge Australia 14 1.2k 1.2× 198 0.6× 438 1.9× 151 1.0× 290 2.1× 17 1.6k
Gabriela Schneider United States 23 729 0.8× 177 0.5× 197 0.9× 123 0.8× 189 1.4× 55 1.1k
Malin Wickström Sweden 27 1.3k 1.4× 420 1.3× 650 2.9× 246 1.6× 112 0.8× 63 2.2k
Maurizio Orlandini Italy 26 1.3k 1.4× 217 0.7× 493 2.2× 78 0.5× 208 1.5× 66 1.9k

Countries citing papers authored by Hui Zeng

Since Specialization
Citations

This map shows the geographic impact of Hui Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Zeng more than expected).

Fields of papers citing papers by Hui Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Zeng. The network helps show where Hui Zeng may publish in the future.

Co-authorship network of co-authors of Hui Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Zeng. A scholar is included among the top collaborators of Hui Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Zeng. Hui Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yue, Juan Du, Guopan Yu, et al.. (2025). Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis. Nature Communications. 16(1). 1358–1358. 6 indexed citations
2.
Yin, Qian, Yu Yao, Yiwen Zhang, et al.. (2025). DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis. Molecular Medicine. 31(1). 71–71. 7 indexed citations
3.
4.
Wang, Rongjie, Yanze Wang, Qiang Fu, et al.. (2024). Coral-inspired fabrication of Ag-Cu2O-zwitterionic polymers-phosphor films with day and night antifouling properties. Ceramics International. 50(22). 46471–46483. 1 indexed citations
5.
Zeng, Hui, Haibo Dong, Min Zhou, et al.. (2024). Negative expression of CD117 predicted inferior OS and PFS in acute promyelocytic leukemia. International Journal of Laboratory Hematology. 46(6). 1052–1058.
6.
Li, Yizhen, Lei Hua, Yue Li, et al.. (2024). Hexamethylene amiloride induces lysosome-mediated cell death in multiple myeloma through transcription factor E3. Cell Death Discovery. 10(1). 505–505. 1 indexed citations
7.
Zhang, Siqi, Xin Gao, Hui Zeng, et al.. (2024). Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 599–610. 3 indexed citations
8.
Li, Shiqi, Hui Zeng, Junli Fan, et al.. (2023). Glutamine metabolism in breast cancer and possible therapeutic targets. Biochemical Pharmacology. 210. 115464–115464. 67 indexed citations
9.
Li, Yue, et al.. (2023). SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients. Frontiers in Genetics. 13. 1081262–1081262. 3 indexed citations
10.
Li, Yue, et al.. (2023). Hexamethylene amiloride synergizes with venetoclax to induce lysosome-dependent cell death in acute myeloid leukemia. iScience. 27(1). 108691–108691. 3 indexed citations
11.
Du, Juan, et al.. (2023). Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia. Leukemia. 37(7). 1407–1412. 8 indexed citations
12.
Zhang, Shaojuan, Weijian Ye, Tianming Zhao, et al.. (2022). Recent developments on the application of molecular probes in multiple myeloma: Beyond [18F]FDG. Frontiers in Bioengineering and Biotechnology. 10. 920882–920882. 1 indexed citations
13.
Zeng, Hui, Zhenlong Yuan, Guochao Zhang, et al.. (2022). Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancer. Translational Lung Cancer Research. 11(7). 1348–1358. 7 indexed citations
14.
Dong, Jialin, Ruijun Xu, Hui Zeng, et al.. (2021). Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes. Bioscience Reports. 41(6). 13 indexed citations
15.
Zeng, Hui, et al.. (2021). XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma. Medicine. 100(1). e24150–e24150. 4 indexed citations
16.
Wang, Huiwen, Tianming Zhao, Wei Liu, et al.. (2020). A Novel miRNA Restores the Chemosensitivity of AML Cells Through Targeting FosB. Frontiers in Medicine. 7. 582923–582923. 8 indexed citations
17.
Zhou, Ting, Tae Wan Kim, Lei Tan, et al.. (2018). A hPSC-based platform to discover gene-environment interactions that impact human β-cell and dopamine neuron survival. Nature Communications. 9(1). 4815–4815. 23 indexed citations
18.
Zhao, Yangjing, Yanhui Chen, Ying Hu, et al.. (2018). Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Translational Cancer Research. 7(2). 231–239. 5 indexed citations
19.
Zeng, Hui, Jingly F. Weier, Mei Wang, et al.. (2012). Bioinformatic Tools Identify Chromosome-Specific DNA Probes and Facilitate Risk Assessment by Detecting Aneusomies in Extra-embryonic Tissues. Current Genomics. 13(6). 438–445. 4 indexed citations
20.
Zeng, Hui, Jung Woo Park, Min Guo, et al.. (2009). Lack of ABCG2 Expression and Side Population Properties in Human Pluripotent Stem Cells. Stem Cells. 27(10). 2435–2445. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhihong Wang Breakdown of academic impact, for papers by Petra Obexer Breakdown of academic impact, for papers by Fengjuan Fan Breakdown of academic impact, for papers by Xueyan Wang Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Joan Chang Breakdown of academic impact, for papers by Alex R. D. Delbridge Breakdown of academic impact, for papers by Gabriela Schneider Breakdown of academic impact, for papers by Malin Wickström Breakdown of academic impact, for papers by Maurizio Orlandini
Rankless by CCL
2026